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Executive Summary  
Background 
In Scotland, and globally, public health systems are coming under increasing pressures due to 
several complex and inter-related factors, including the lack of capacity within the primary 
care workforce and an expanding population of older people. Older people often have 
multiple conditions and the associated increase in medicines use and healthcare 
appointments has led to an overwhelming medicines and healthcare service burden; 
adversely impacting patients’ quality of life and access to primary care services.  A key 
element of the Scottish response is the better integration and transformation of our health 
and social care services, and a shift in the balance of care from hospital to the community 
setting.1 This direction of travel has brought focus to primary care, the challenges and 
pressures facing frontline practitioners and the need to transform services through building 
broader multidisciplinary teams (MDTs).   The clinical leadership community has shaped and 
endorsed the 2020 Vision for our public services with clear policy direction and supporting 
policy documents: Achieving Excellence in Pharmaceutical Care – a Strategy for Scotland 
(2017) commits to “Integrating pharmacists with advanced clinical skills and pharmacy 
technicians in GP Practices to improve pharmaceutical care and contribute to the 
multidisciplinary team2, and, Practicing Realistic Medicine (2018), states that “by 2025, 
everyone who provides healthcare in Scotland will demonstrate their professionalism 
through the approaches, behaviours and attitudes of Realistic Medicine”. 3 
Nationally, and internationally, the contribution which pharmacists make to improving care 
when integrated into MDT in primary care has been recognised.4  In Scotland, a major step 
change has been the announcement in 2015 of a three-year funding package through The 
Primary Care Fund (£16.2m) to recruit up to 140 whole time equivalent pharmacists to work 
directly with GP Practices. This was augmented by a further £4.2m in 2017/18 to work 
towards the Scottish Government commitment that all GP Practices have access to a 
                                                        
1 Scottish Government (2013) ‘Route Map’ to the 2020 Vision for Health and Social Care in Scotland. Available at 
http://www.gov.scot/Topics/Health/Policy/Quality-Strategy/routemap2020vision 
2 Scottish Government (2017) Achieving Excellence in Pharmaceutical Care: A Strategy for Scotland. Available at 
http://www.gov.scot/Publications/2017/08/4589 
3 Scottish Government (2018) Chief Medical Officer for Scotland Annual Report 2016/17: Practising Realistic Medicine. 
Available at http://www.gov.scot/ISBN/9781788514279 
4 Weeks G, George J, MacLure K, Stewart D. (2016) Non-medical prescribing versus medical prescribing for acute and 
chronic disease management in primary and secondary care. Cochrane Database Systematic Review, 11: CD011227. 
pharmacist with advanced clinical skills and supported the recruitment of pharmacy 
technicians.5 6 
 
Evaluation Approach  
In July 2017, the Scottish Government Pharmacy and Medicines Division commissioned an 
evaluation of the current pharmacy team involvement in GP Practices across Scotland.  This 
commission, undertaken jointly by the University of Strathclyde and Robert Gordon 
University, focused on three broad areas of deliverables: workforce development; service 
activity; and, service and patient outcomes.   
The evaluation took a mixed methods approach comprising:  
 A national workforce survey to characterise the pharmacy teams and activities 
undertaken;  
 Workforce mapping across the GP Practice setting and undertaking some early 
workforce modelling; 
 In-depth case studies in selected GP Practices to understand integration within the 
wider MDT and the views of patients who had a consultation with the case study 
pharmacist. 
 
Evaluation Results  
Deliverable 1 – Workforce Development (GP Pharmacy Team) 
The national workforce survey, distributed as an online questionnaire in November 2017, to 
all 14 NHS Health Boards, was completed by most pharmacists (n=393/471, 83.4%) and 
pharmacy technicians (n=101/112, 91.8%) working in GP Practices across Scotland. Table 1 
presents a summary of the demographics, postgraduate education and training and 
employment characteristics of the workforce.   
 
                                                        
5 Scottish Government (2015) Primary Care Funding Allocation for Pharmacists in GP Practices and Additional Prescription 
for Excellence Funding.  Available from: http://www.sehd.scot.nhs.uk/pca/PCA2015(P)16.pdf 
6 Scottish Government (2017) Primary Care Funding - Allocation for Pharmacists in GP Practices 2017-18. Available from: 
http://www.sehd.scot.nhs.uk/pca/PCA2017(P)04.pdf 
 Table 1 – NHS Scotland GP Pharmacy Team Workforce Profile, November 2017 
 Pharmacist 
(n= 393/471, 83.4%) 
Pharmacy Technician 
(n=101/112, 91.8%) 
Gender 83% female 90% female 
Age 34% aged 30-39 35% aged 30-39 
Time qualified 42% qualified over 20 years 35% qualified over 20 years 
Experience in GP Practices 57% have up to 4 years’ 
experience in GP Practices 
66% have up to 4 years’ experience in 
GP Practices 
Funding source 92% funded by health board 87% funded by health board 
Contract type 50% permanent full-time 46% permanent full-time 
Agenda for Change (AfC) band 47% AfC Band 7 82% AfC Band 5 
Postgraduate qualifications 65% have up to four PG 
qualifications (32.6% do not have 
a PG qualification) 
83% have at least one qualification 
Prescribing status 68% prescribers (of which 72.3% 
actively using) 
NA 
 
The broad results indicate that pharmacy teams represent a diverse, well-educated and 
experienced group of people, with pharmacist and pharmacy technicians most commonly 
reporting being qualified for 20 or more years.  However, over fifty percent of pharmacists 
and sixty percent of pharmacy technicians had worked in GP Practice for four or less years.  
Most pharmacists and pharmacy technicians had experience in community pharmacy and/or 
hospital pharmacy.  The pharmacists were predominantly practicing independent prescribers. 
Over sixty percent of pharmacists reported having postgraduate qualifications and eighty 
percent of technicians had completed at least one additional qualification.   
Pharmacists and pharmacy technicians were both primarily funded by an NHS Health Board 
on a permanent contract. Pharmacists were most commonly part-time whereas pharmacy 
technicians were generally full-time.  Pharmacy teams are working across multiple general 
practices, more so for technicians undertaking a wide range of activities, roles and clinics. 
Just under half on the pharmacists are employed at Band 7 (47%) and most pharmacy 
technicians, Band 5 (82%). 
Deliverable 2 – Service Activity (GP Pharmacy Team)  
A national map profiling GP Practices which have pharmacy teams was created. The data in 
the GP Profiling Map included practice information, demographics, workforce (number of 
GPs, pharmacists, technicians), prescribing features, prescribing indicators, and pharmacy 
team members’ hours worked per week.  
Of those who completed the workforce survey (pharmacists n=393, 83.4%; pharmacy 
technicians n=101, 91.8%), the workforce equated to approximately 202.3 whole time 
equivalent (wte) pharmacists and 57.3 wte technicians. The pharmacy workforce clearly 
identified with being part of the MDT and self-reported confidence and competence in 
working within the wider team and dealing with patients. Over three-quarters of the 
pharmacists were currently undertaking medication/polypharmacy reviews (78%), and over 
half medicines reconciliation (56%), hospital discharge letters (54%) and 
monitoring/reviewing high risk medicines (52%). Activities for pharmacy technicians included 
medicine safety reviews/recalls (41%), medication/polypharmacy reviews (40%) and 
medicines reconciliation (31%) with the majority undertaking prescribing efficiency work 
(79%).  Figure 1 presents a summary of the main clinical activities of the GP Pharmacy Team.  
 
 
Figure1 – NHS Scotland GP Pharmacy Team Service Activity Profile, November 2017.  
Initial workforce modelling, building on the national survey and limited localised more 
granular data, examined the time pharmacists spent on undertaking polypharmacy clinics and 
acute medication requests in two NHS Health Boards.  The work enabled some Scottish 
resource estimates for undertaking polypharmacy clinics, stratified for different patient 
Pharmacist Service Activity
•up to 29 GP practices: median 2 (IQR 2-5)
•78% medication/polypharmacy reviews
•76% prescribing efficiency work
•72% interpreting prescribing data
•60% providing training for other staff
•59% audit/service improvement work
•56% medicines reconciliation
•54% hospital discharge letters
•52% monitoring/review of high risk 
medicines
•47% hospital outpatient requests
•44% acute medication requests
•41% medicine safety reviews/recalls
•30% chronic disease clinics (inc. prescribing) 
Pharmacy Technician Service Activity
•up to 54 GP practices: median 5 (IQR 3-8)
•79% prescribing efficiency work
•68% interpreting prescribing data
•57% audit/service improvement work
•55% providing training for other staff
•41% medicines safety reviews/recalls
•40% medication/polypharmacy reviews
•31% medicines reconciliation
population scenarios while using different estimates of time taken to undertake a review 
(Table 2).  The estimation of resource necessary for managing acute medication requests was 
very limited, utilising electronic data from only 15 GPs in NHS GG&C to derive an estimate of 
annual acute scripts per patient processed by pharmacists, and thus needs caution in 
interpretation. This highlights the need for improved data capture.   
 
Table 2 - The number of whole time equivalent (WTE) pharmacists to deliver polypharmacy reviews over a 12 month 
period for NHS Scotland 
 
 
NHS GG&C 
(32 mins/ 
review) 
 
NHS LOTHIAN 
(30 mins/ 
review) 
 
POLYPHARMACY 
GUIDANCE 2018 
Minimum 
(40 mins) 
Maximum 
(120 mins)1 
 Age 
(years) 
Number 
of 
Patients 
WTE WTE WTE WTE 
Scenario 1: NHS Scotland patients 
dispensed medicines from 10 or 
more BNF section, including at least 
one high risk medicine, within a six 
month period2  
50+ 272,442 84.2 79.0 105.3 315.9 
65+ 189,789 58.7 55.0 73.3 220.0 
75+ 108,683 33.6 31.5 42.0 126.0 
Scenario 2: SPARRA3 patients aged 
50 years and older, residing in a 
care home4. These patients have 
any risk score (1%-99%). 
50+ 30,483 9.4 8.8 11.8 35.3 
Scenario 3:  SPARRA patients with a 
risk score of 40-60% who were 
dispensed items from 10 or more 
BNF sections 
65+ 54,190 16.8 15.7 20.9 62.8 
75+ 42,882 13.3 12.4 16.6 49.7 
1 Assumed to take into account follow-up, MDT meetings, practice meetings and/or other activities;  
2 Data from NHS Scotland Prescription Information System dataset. Figure reflects the number of patients in NHS Scotland who 
received medicines from 10+ BNF section and one high risk medicine in the six months before December 2017;  
3 SPARRA (Scottish Patients At Risk of Readmission and Admission) data for the 1st May, 2017;  
4 Not necessarily polypharmacy patients who are dispensed items from 10 or more BNF sections. 
 
Deliverable 3 – Service and Patient Outcomes (GP Pharmacy Team) 
The Scotland-wide case studies focused on seven pharmacist independent prescribers each 
working across one or two general practices and delivering patient facing care. It comprised 
interviews with the pharmacist, their patients and the broader healthcare team. Patients also 
completed a questionnaire which included the CARE 7(Consultation and Relational Empathy) 
                                                        
7 S.W. Mercer, D.J. Murphy, (2008) "Validity and reliability of the CARE Measure in secondary care", Clinical Governance: 
An International Journal, Vol. 13 Issue: 4, pp.269-283, https://doi.org/10.1108/14777270810912969 
Measure. While accepting the limitations of case studies in terms of issues of generalisability 
and transferability of findings, and the relatively low patient survey response rate (n=121) it is 
clear that patient questionnaire feedback is very positive in terms of the quality of the 
consultation and beliefs and confidence in the skill, knowledge and ability of the pharmacists 
(all rated very good / excellent by the majority of patients)  This was further evidenced by 
patients during interviews (n=24) across six of the seven case studies. 
From the qualitative interviews with GP Practice staff (n= 18), there was enthusiasm for and 
appreciation of the pharmacist’s role in GP Practice. They were viewed as medicines 
specialists, prescribing support advisors and point of contact for communication with 
community and hospital pharmacy teams. In addition, some were keen to recognise the 
value to patients of having different healthcare professionals working together and the 
added value of different perspectives for person-centred care.  Figure 2 presents some 
illustration of the patient and GP staff voice captured.  Pharmacists themselves felt accepted 
and integral to the GP Practice team, reporting that they enjoyed the challenge and 
responsibility of a more clinical patient-facing role. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 - Patient and GP Practice Team voices from in-depth case studies (n=7), April to July 2018 
‘I think it depends how you sort of see your 
doctor and see the pharmacist whether you see 
them as peers as opposed to thinking doctors are 
gods and they are pharmacists are only Chemists. 
But if you see them both as professional people 
that they know what talking about’ (Patient_19) 
‘For me would be 
someone that dealt with 
medicines primarily…it’s 
a totally different 
profession for me’ 
(Patient_8) 
‘I’m not sure what 
they are capable 
of or allowed to 
actually do 
compared to a 
doctor’ (Patient 2) 
‘It’s absolutely the way forward…it’s more 
than a positive thing…to be having a 
pharmacist on board for inter-professional 
learning, patient safety…it’s all there…it’s 
made such a difference – particularly to our 
GP colleagues’ (GP4) 
‘There is a big cultural difference…approach to risk 
is radically different from GP and pharmacist 
backgrounds…was biggest issue…we are trained in 
it, we’re honed in it, spend years learning about 
decision making…that’s something pharmacists 
aren’t trained in…they are more risk averse (GP2) 
‘He really considers what works for the patients…he’ll do telephone consultations, face-to-face, going to 
see them in their home…that’s what really shone through…doing a much better job…it’s a much more 
person-centred approach…we’re all striving for that, but it’s much more evident with the pharmacist 
going out to do it’ (Senior Nurse Primary Care) 
Strengths and limitations of the evaluation  
The support from senior stakeholders and engagement at scale of the pharmacy teams 
working in general practice has enabled this evaluation to gather and assimilate a wealth of 
knowledge and understanding regarding how Scotland is growing the pharmacy GP 
workforce, the activities they are performing, and how this is being perceived by both the 
wider GP team and patients. The high response rates attained in the survey suggest that the 
results are generalisable and are representative of the workforce across Scotland. However, 
the evaluation was challenged by the paucity of routinely collected data which limited:  the 
ability to evidence changes in GP Practice / NHS Board patient clinical outcomes and any 
unintended consequences; time profiling the developing activity within the GP Practice; and 
estimating the capacity of GP time released.  The data collection from the survey and case 
studies may have been influenced by social-desirability bias, while the survey data might also 
have been influenced by acquiescence bias. Additionally, the validity of the self-reported data 
could not be confirmed.  The survey questionnaire was lengthy for participants to complete, 
as keeping it concise while meeting the deliverables was challenging, and relied on the 
goodwill of the respondents to give their time in sharing information. Additionally, the 
scheduling of patient, pharmacist and their GP Practice colleagues for interview was 
challenging and, once again, relied on the goodwill of interviewees. 
Conclusion  
This evaluation clearly demonstrates the significant progress already made in establishing 
pharmacy teams within the wider GP Practice setting but also highlights the challenges faced 
by this expanding practitioner group. The landscape continues to change and evolve, 
including the recent agreement of the new pharmacotherapy service to be supported by 
pharmacy teams as part of the GMS contract 2018.8 Consequently, it is important that there 
is continued focus and effort in supporting our evolving GP Practice-based pharmacy 
workforce as they integrate more fully into the broader primary care MDT. 
 
                                                        
8 Scottish Government. The 2018 General Medical Services in Scotland: Contract Framework. The Scottish 
Government.2017; https://www.gov.scot/Publications/2017/11/1343 
Recommendations 
The recommendations detailed in Figure 3, are principally focused on what health policy 
leaders and health service providers should consider to support future service provision, 
review and improvement, enabled through efficient routine data collection, accompanied by 
targeted in-depth qualitative investigations.  The outcome will be the ability to more rapidly 
and effectively examine and quantify the evolving contribution of the GP Practice-based 
pharmacy team moving forward. 
   
 
 
  
Figure 3: Recommendations 
This evaluation serves as a foundation on which to develop a strong evidence base to 
demonstrate the impact of this evolving workforce on patient care.  Future evaluations 
should consider the following areas: 
 Establish job profiles for evolving pharmacy team roles to inform sustainable job 
planning. 
 Examine standardisation of work activities to enable improved quantification of work 
processes to inform workforce modelling.  
 Establish national collection, curation and analysis of primary care pharmacy team activity 
and outcome measures (e.g. disease specific clinical measures, care bundle compliance, 
polypharmacy metrics, prescription cost and volume) to assess service impact. 
 Extend evaluation of the impact of the GP Practice pharmacy team on the broader 
multidisciplinary team encompassing the hospital and community pharmacy workforce.  
 Deploy regular national workforce survey to meet emerging needs - including the 
evolving pharmacotherapy service 
 Conduct regular patient surveys to evaluate patients’ experiences of pharmacist led 
clinics.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
